Copyright
        ©The Author(s) 2023.
    
    
        World J Gastrointest Surg. Nov 27, 2023; 15(11): 2413-2422
Published online Nov 27, 2023. doi: 10.4240/wjgs.v15.i11.2413
Published online Nov 27, 2023. doi: 10.4240/wjgs.v15.i11.2413
		Figure 1 Liver function indices before and after surgery.
		
			 A: Alanine aminotransferase; B: Aspartate aminotransferase; C: Total bilirubin; D: Direct bilirubin concentrations before (orange) and after (green) surgery. aP < 0.05; bP < 0.01; dP < 0.0001. ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; TBIL: Total bilirubin; DBIL: Direct bilirubin.
		
	
		Figure 2 Renal function markers before and after surgery.
		
			 A: Creatinine; B: Blood urea nitrogen concentrations before (orange) and after (green) surgery. cP < 0.001, dP < 0.0001. Cr: Creatinine; BUN: Blood urea nitrogen.
		
	
		Figure 3 Three-year survival curves of independent prognostic factors.
		
			 A: Overall survival; B: Tumor stage; C: Distant metastasis; D: Treatment plan. HIPEC: Hyperthermic intraperitoneal chemotherapy.
		
	
- Citation: Wu JX, Hua R, Luo XJ, Xie F, Yao L. Effects of cytoreductive surgery combined with hyperthermic perfusion chemotherapy on prognosis of patients with advanced gallbladder cancer. World J Gastrointest Surg 2023; 15(11): 2413-2422
 - URL: https://www.wjgnet.com/1948-9366/full/v15/i11/2413.htm
 - DOI: https://dx.doi.org/10.4240/wjgs.v15.i11.2413
 
